Cancer risks lowered with increased physical activity supriya kashyap kashyap17 May 2016 12:52 PM ISTHigher levels of leisure-time physical activity were associated with lower risks for 13 types of cancers, according to a new study published online by...
Nice Guidelines on Diagnosis and Management of Myeloma 2016 supriya kashyap kashyap26 Jun 2016 4:15 PM ISTMyeloma is a type of cancer that develops from cells in the bone marrow called plasma cells. Bone marrow is the spongy tissue found inside the inner...
Blood cancer treatment may severely weaken immune cells supriya kashyap kashyap3 Sept 2016 11:36 AM ISTNew York : Some blood cancer treatments can cause a long term effect premature ageing of important disease fighting cells, says a study.The...
New Research yields hope for amyloidosis supriya kashyap kashyap6 Dec 2016 9:03 AM ISTTwo new treatments are showing promise and overall survival is on the rise for AL amyloidosis, according to a series of studies involving researchers...
New drug delivery method for cancer therapy developed supriya kashyap kashyap19 March 2017 9:18 AM ISTScientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new drug delivery method that produces strong results in...
CAR T, immunotherapy bring new hope for multiple myeloma patients Anjali Nimesh Nimesh20 Dec 2017 7:10 PM ISTTwo investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the...
Once weekly carfilzomib, promising for refractory myeloma patients Medha Baranwal Baranwal30 Jun 2018 7:05 PM ISTOnce weekly carfilzomib appears safe and more effective with a convenient dosing regimen versus the twice-weekly schedule for the treatment of...
New drug improves survival in multiple myeloma patients: Lancet Medha Baranwal Baranwal19 Dec 2018 7:15 PM ISTUK: A therapeutic drug, called lenalidomide, has shown improved outcomes and survival rates in patients with a serious type of bone marrow cancer...
Prophylactic levofloxacin reduces infection and death risk in myeloma patients: TEAMM trial Medha Baranwal Baranwal5 Nov 2019 7:25 PM ISTUK: Addition of prophylactic levofloxacin to active myeloma treatment during the first 12 weeks of therapy (after the diagnosis) reduces the risk of...
2016 in Retrospect : World of medicine supriya kashyap kashyap28 Dec 2016 9:00 AM ISTNew Delhi : The rapid rise of the Zika infections across many parts of the world had a large section of the population mightily worried till its...
